Skip to main content
Amye Tevaarwerk, MD, Oncology, Rochester, MN, Mayo Clinic Hospital - Rochester

AmyeJ.TevaarwerkMD(She/Her)

Oncology Rochester, MN

Breast Cancer, Clinical Informatics

Mayo Clinic Cancer Center

Dr. Tevaarwerk is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Tevaarwerk's full profile

Already have an account?

Summary

  • I am a medical oncologist specializing in breast cancer with expertise in cancer survivorship and oncology informatics. Along with patient care, my research focus is to develop tools that will:
    a) increase care coordination and communication between survivors and health care providers, particularly in the post-active treatment phase
    b) decrease the effects of cancer diagnosis and treatment on work and employment

    To support this mission, I have received funding from various sources including NIH, NIDDR, ICTR and investigator initiated funding. I have also published numerous manuscripts in scientific journals including the Journal of Clinical Oncology, Cancer and Journal of Oncology Practice. I am currently an Associate Editor for the Journal of Cancer Survivorship, and have served on the NCCN's Survivorship Panel and EHR Advisory Board as well as the Epic Oncology Specialty Steering Board.

    Much of my research to date has focused on leveraging the EHR to facilitate 360-degree communication between health care providers (cancer and non-cancer) as well as survivors. As such, I have expertise in working with EHR analysts and software designers to develop healthcare IT (I am also an Epic-certified physician builder). Having served as the Principle Investigator for both investigator-initiated and national cooperative groups, I have experience writing grants, developing protocols and the day-to-day running of both supportive and developmental therapeutic trials. I collaborate closely with IT, Industrial and Human Factors Engineering, Nursing, Kinesiology and Primary Care.

Education & Training

  • University of Wisconsin Hospitals and Clinics
    University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 2006 - 2008
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2002 - 2005
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 2002
  • Washington University
    Washington UniversityB.A., Major in Biochemistry and Anthropology, Minor in German Language, 1994 - 1998

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 2006 - 2025
  • MO State Medical License
    MO State Medical License 2005 - 2025
  • MN State Medical License
    MN State Medical License 2021 - 2025
  • IL State Medical License
    IL State Medical License 2011 - 2014
  • American Board of Internal Medicine Medical Oncology
  • American Board of Preventive Medicine Clinical Informatics

Awards, Honors, & Recognition

  • UW Health Physician Excellence Award Honoree 2016
  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
  • KL2 Scholar 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Survivor and Clinician Assessment of Survivorship Care Plans for Hematopoietic Stem Cell Transplant Patients: An Engineering, Primary Care, and Oncology Collaborative ...  
    Morken CM, Tevaarwerk AJ, Swiecichowski AK, Haine JE, Williams ZT, Norslien K, Arroyo N, Zhang X, Campbell B, Mendonca EA, Juckett MB, Sesto ME, Biol Blood Marrow Transplant, 1/11/2019
  • Impact of Survivorship Care Plans and Planning on Breast, Colon and Prostate Cancer Survivors in a Community Oncology Practice  
    Hua A, Sesto Me, Zhang X, Wassenaar TR, Tevaarwerk AJ, J Cancer Educ, 1/4/2019
  • Double-Blind Phase III Trial of Adjuvant Chemotherapy With and and hout Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast Cance...  
    Miller KD, O'Neill A, Gradishar W, Hobday TJ, Goldstein LJ, Mayer IA, Bloom S, Brufsky AM, Tevaarwerk AJ, Sparano JA, Le-Lindqwister NA, Hendricks CB, Northfelt DW, Da..., J Clin Oncol, 1/1/2018
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Prospective Study of Work Limitations in Cancer Patients (pts) Undergoing Curative Chemotherapy (CT)
    Tevaarwerk, A et al, Cancer Survivorship Symposium, 1/1/2017
  • A primary care education program regarding cancer survivorship care plans at the University of Wisconsin (UW)
    Haine JM, Trowbridge ER, Kamnetz SA, Feldstein D, Wilke LG, Donohue SM, Sesto M, Tevaarwerk AJ, Cancer Survivorship Symposium, 1/1/2017
  • Cancer survivorship care plan (SCP) impact on clinical decision making at point-of-care visits with Primary Care Providers (PCPs) at the University of Wisconsin (UW)
    Donohue SM, Haine JM, Trowbridge ER, Kamnetz SA, Feldstein D, Sosman J, LI Z, Wilke LG, Sesto M, Micek M, Tevaarwerk AJ, SGIM, 1/1/2017
  • Join now to see all

Lectures

  • Coordinating Care for Cancer Survivors: Bridging the Gap Between Oncology and Primary Care 
    1/1/2019
  • Shaping the Future: Late and Long-Term Health Considerations and Management Strategies for Young Cancer Survivors 
    UW Carbone Cancer Center, Madison, WI - 1/1/2018
  • Title TBD 
    Madison, WI - 1/29/2017
  • Join now to see all

Other

  • Genetic Risk of Breast Cancer 
    Tevaarwerk A, TV-3 interview with Charlotte Deleste
    1/1/2007

Authored Content

  • Patient-Reported Outcomes in Oncology: Be Proactive Not ReactiveApril 2023

Press Mentions

  • Patient-Reported Outcomes in Oncology: Be Proactive Not Reactive
    Patient-Reported Outcomes in Oncology: Be Proactive Not ReactiveApril 13th, 2023
  • Lack of Financial Comfort Linked to Weight Gain Among Young Breast Cancer Survivors
    Lack of Financial Comfort Linked to Weight Gain Among Young Breast Cancer SurvivorsSeptember 11th, 2022
  • Expert Explains Individualized Decision on Endocrine Therapy Beyond 5 Years in Breast Cancer
    Expert Explains Individualized Decision on Endocrine Therapy Beyond 5 Years in Breast CancerMay 22nd, 2017
  • Join now to see all

Professional Memberships

Other Languages

  • Dutch

Hospital Affiliations